血压变化与对比性脏病的关联 STEMI 患者接受初级PCI
Cahit Coskun1, Semih Eren2, Feyza Mollaalioglu2
1Ministry of Health Demirci State Hospital, Cardiology Dr. Mehmet Akarsu Street Demirci, Manisa.
Acta Cardiologica Sinica
|November 28, 2025
概括
血压变化 (BPV) 与ST升高心肌梗塞 (STEMI) 患者的对比诱导性脏病 (CIN) 有关. 高缩BPV,特别是缩标准偏差和平均真实变异性,独立预测PCI后的CIN发展.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 临床生理学 临床生理学
背景情况:
- 在全球范围内,ST段升高心肌梗塞 (STEMI) 仍然是导致死亡的首要原因.
- 对比诱导性脏病 (CIN) 在STEMI患者中复杂化皮肤冠状动脉干预 (PCI),增加发病率和死亡率.
- 血压变化 (BPV) 与不良的心血管结果和功能障碍有关,但其与CIN的关联是未知的.
研究的目的:
- 研究在接受PCI的STEMI患者中短期侵入性测量BPV和CIN之间的关系.
- 为了确定预测CIN发展的特定BPV参数.
主要方法:
- 对220名血液动力学稳定的STEMI患者进行PCI的前性研究.
- 在PCI后6小时,通过大腿进行侵入性血压监测.
- 使用通用公式计算心和腹标准偏差 (SD) 和平均真实变化率 (ARV).
主要成果:
- 在短期BPV和CIN发展之间发现了显著的关联 (p < 0.01).
- 缩BPV参数,特别是缩SD (OR: 1.055,p=0.04) 和缩ARV (OR: 1.084,p=0.02),被确定为CIN的独立预测因素.
结论:
- 在动脉内测量的短期BPV与STEMI患者的CIN发展有关.
- 缩性SD和缩性ARV是CIN的独立预测剂,可能有助于早期诊断和预防.
- 需要进一步的大规模试验来确认BPV作为CIN风险的临床指标.
更多相关视频
相关概念视频
01:17Measurement of Blood Pressure
2.6K
Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a...
2.6K
01:10Pre-Procedural Guidelines for Assessing Blood Pressure
791
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
791
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
326
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
326
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
443
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
443
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
521
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
521
01:28Special considerations while measuring blood pressure
1.1K
When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
1.1K